Microbot Medical Inc (MBOT) Stock Price, Quote & News

Company Profile

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides No...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 781 875 3605

Website: microbotmedical.com

Address:

175 Derby Street, Bld. 27, Hingham, United States

ltinvestorx Dec. 5 at 10:41 AM

$MBOT Microbot has not disclosed LIBERTY’s unit product cost. For a single‑use robotic system, this figure is critical. Without it, commercial viability can’t be evaluated, and that uncertainty is probably weighing on the stock price.

0 · Reply

Iightning Dec. 5 at 6:43 AM

1ightning® Premium Options Alert (Actionable) Ticker: $MBOT Contract: Dec 19 $2C Entry: 0.50 Exit: 0.65 Return: +30.87% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

stockWare Dec. 5 at 2:37 AM

$RR https://x.com/RichtechRobots/status/1996673604059316488 $IRBT $SERV $ASTS $MBOT

0 · Reply

Iightning Dec. 5 at 12:32 AM

1ightning® Premium Options Alert (Actionable) Ticker: $MBOT Contract: Dec 19 $2C Entry: 0.50 Exit: 0.65 Return: +30.87% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

__AvengerTrader Dec. 4 at 11:36 PM

What is happening to ticker SNSE now?! Looks like they are going to SQUEEZE ticker SNSE up next .. SNSE is breaking out like crazy.. Its insane what's going on in this market.. Looks like all eyes are going to SNSE now.. $CIFR $HIVE $PATH $MBOT x-

0 · Reply

AvengerTrader Dec. 4 at 9:18 PM

1 · Reply

ChaseDeluca Dec. 4 at 8:34 PM

KSCP .....Global demand for automation and “smart security” is exploding for corporate campuses, institutions, logistics centers, infrastructure, and more. $KSCP is squarely positioned at that intersection: robotics + AI + physical security. Their service-based model reduces upfront cost barriers for clients making adoption much more scalable and repeatable. If the broader robotics / automation wave starts catching mainstream investor attention again, KSCP could re-rate sharply especially because it’s so under-valued relative to its real world tech. $RR $UAVS $KITT $MBOT ....

0 · Reply

RunnerSignals Dec. 4 at 8:33 PM

$CAPR $MBOT $CMPX $EVTL $TARA biotech boom in motion! Massive upside potential, who is ready to ride the rocket? https://stocksrunner.com/news/2025-12-04-stock-upgrades-today-highlight-top-picks

0 · Reply

Daquanladariusblackman3 Dec. 4 at 5:30 PM

$MBOT 3rd week of this month imo. When I was talking with investor relations about once or twice a week Michael made it emphatically clear that once they got the ball rolling they wanted to hit the ground running. They spent a lot of time getting the sales team in place and have had plenty of time to work out a strategy. Now is the time to attack, it won’t take long.

1 · Reply

Logic102 Dec. 4 at 4:47 PM

$MBOT Only thing holding back 3.50+ is the announcement of a second hospital system. Dunno if this happens before the holidays or after, but it's coming.

1 · Reply

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Nov 5, 2025, 8:30 AM EST - 4 weeks ago

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Oct 16, 2025, 8:30 AM EDT - 7 weeks ago

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

Oct 14, 2025, 8:30 AM EDT - 7 weeks ago

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

Oct 7, 2025, 8:00 AM EDT - 2 months ago

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Oct 1, 2025, 9:00 AM EDT - 2 months ago

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Sep 23, 2025, 8:30 AM EDT - 2 months ago

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Sep 16, 2025, 3:37 PM EDT - 2 months ago

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Sep 15, 2025, 8:00 AM EDT - 2 months ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

Sep 9, 2025, 8:28 AM EDT - 3 months ago

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Sep 8, 2025, 8:28 AM EDT - 3 months ago

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Aug 28, 2025, 3:57 PM EDT - 3 months ago

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

Aug 20, 2025, 8:30 AM EDT - 3 months ago

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Aug 5, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Jul 22, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Jul 8, 2025, 8:30 AM EDT - 5 months ago

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Jun 30, 2025, 8:30 AM EDT - 5 months ago

Microbot Medical® Added to the Russell Microcap® Index

Jun 17, 2025, 8:30 AM EDT - 6 months ago

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Jun 9, 2025, 8:30 AM EDT - 6 months ago

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Jun 5, 2025, 8:30 AM EDT - 6 months ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Apr 23, 2025, 8:30 AM EDT - 8 months ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Apr 9, 2025, 8:30 AM EDT - 8 months ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Apr 1, 2025, 8:30 AM EDT - 8 months ago

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Mar 4, 2025, 8:30 AM EST - 9 months ago

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Feb 25, 2025, 8:30 AM EST - 10 months ago

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Feb 11, 2025, 6:15 PM EST - 10 months ago

Microbot Medical Closes $13 Million Registered Direct Offering

Feb 10, 2025, 8:00 AM EST - 10 months ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jan 10, 2025, 10:25 AM EST - 11 months ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 7, 2025, 4:15 PM EST - 11 months ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Dec 30, 2024, 8:30 AM EST - 1 year ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 10, 2024, 10:18 AM EST - 1 year ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Oct 15, 2024, 8:38 AM EDT - 1 year ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Sep 30, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Aug 22, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Jul 9, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Jul 8, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Jul 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Jun 20, 2024, 8:25 AM EDT - 1 year ago

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Jun 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Jun 4, 2024, 4:20 PM EDT - 1 year ago

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 3, 2024, 12:11 PM EDT - 1 year ago

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Apr 29, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Apr 15, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Shares Status Following Recent Geopolitical Events

Feb 5, 2024, 7:30 AM EST - 1 year ago

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Jan 30, 2024, 7:20 AM EST - 2 years ago

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

ltinvestorx Dec. 5 at 10:41 AM

0 · Reply

Iightning Dec. 5 at 6:43 AM

1ightning® Premium Options Alert (Actionable) Ticker: $MBOT Contract: Dec 19 $2C Entry: 0.50 Exit: 0.65 Return: +30.87% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

stockWare Dec. 5 at 2:37 AM

$RR https://x.com/RichtechRobots/status/1996673604059316488 $IRBT $SERV $ASTS $MBOT

0 · Reply

Iightning Dec. 5 at 12:32 AM

1ightning® Premium Options Alert (Actionable) Ticker: $MBOT Contract: Dec 19 $2C Entry: 0.50 Exit: 0.65 Return: +30.87% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

__AvengerTrader Dec. 4 at 11:36 PM

0 · Reply

AvengerTrader Dec. 4 at 9:18 PM

1 · Reply

ChaseDeluca Dec. 4 at 8:34 PM

0 · Reply

RunnerSignals Dec. 4 at 8:33 PM

$CAPR $MBOT $CMPX $EVTL $TARA biotech boom in motion! Massive upside potential, who is ready to ride the rocket? https://stocksrunner.com/news/2025-12-04-stock-upgrades-today-highlight-top-picks

0 · Reply

Daquanladariusblackman3 Dec. 4 at 5:30 PM

1 · Reply

Logic102 Dec. 4 at 4:47 PM

$MBOT Only thing holding back 3.50+ is the announcement of a second hospital system. Dunno if this happens before the holidays or after, but it's coming.

1 · Reply

GapUp103 Dec. 4 at 3:39 PM

$MBOT MMs have held this below $2.50 for long enough… let it run $3+ incoming

0 · Reply

Bullly Dec. 4 at 3:36 PM

$MBOT get to 5 , New buyers, going to ? Worldwide acceptance ?

1 · Reply

Logic102 Dec. 4 at 3:34 PM

$MBOT This stock checks all the boxes of being worthy of a 5% or more holding in one's portfolio here. Beaten down share price with an approved disruptive product just beginning adoption. Financial stability with limited dilution risk, superb medical advisory team with diverse health system connections. Remarkable TAM for the main product with a laser focus on ramping sales in the most logical area first. Buy the dips. Even if you are a trader, hold 50% and trade 50%. This one's a winner.

0 · Reply

Dayfu Dec. 4 at 3:06 PM

$MBOT Alguien más se le congelo el precio?

1 · Reply

Logic102 Dec. 4 at 3:04 PM

$MBOT The strength of buying the dips when you have high confidence in the mid- and long-term tailwinds: in a very different space, I have been accumulating $ET over the past 3 months on dips. If you look at the chart you would think I would be down significantly, but I am actually up .9% along with the 8% dividend. Buy any dips here with MBOT as this is clearly a well-run company at a great price. The future is bright.

1 · Reply

Joe_088 Dec. 4 at 2:46 PM

$MBOT Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

0 · Reply

FLNY Dec. 4 at 2:02 PM

$MBOT

0 · Reply

Logic102 Dec. 4 at 1:50 PM

$MBOT She wants to run. There's a big gap to fill to 4.50.

0 · Reply

Pinecone_Tradingz_ Dec. 4 at 12:11 PM

Banked up $8.4K profits on that run! Thank you! Made my whole month! Make sure you FOLLOW @ICEMAN_ALERTS below, Great trader!! He calls them early before anyone else. Love adding before the runs✅ Top watch $NNDM $LCID $CIFR $MBOT now

0 · Reply

Joe_088 Dec. 4 at 9:16 AM

$MBOT any news today will be amazing

0 · Reply

Freshyone Dec. 4 at 8:51 AM

$MBOT ~ Rocket ready🚀

0 · Reply

Iightning Dec. 4 at 8:10 AM

1ightning® Premium Options Alert (Actionable) Ticker: $MBOT Contract: Dec 19 $2C Entry: 0.55 Exit: 0.70 Return: +26.82% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Market Cap	167.22M
Revenue (ttm)	0.00
Net Income (ttm)	-11.44M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	5,033,200
Avg Vol	2,950,802
Day's Range	N/A - N/A
Shares Out	67.16M
Stochastic %K	93%
Beta	1.17
Analysts	Sell
Price Target	$12.00